SBIO Long Call Strategy
SBIO (ALPS Medical Breakthroughs ETF), in the Financial Services sector, (Asset Management industry), listed on AMEX.
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.
SBIO (ALPS Medical Breakthroughs ETF) trades in the Financial Services sector, specifically Asset Management, with a market capitalization of approximately $185.0M, a beta of 0.99 versus the broader market, a 52-week range of 29.9-63.25, average daily share volume of 32K, a public-listing history dating back to 2014. These structural characteristics shape how SBIO etf options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.99 places SBIO roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. SBIO pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a long call on SBIO?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current SBIO snapshot
As of June 30, 2026, spot at $64.69, ATM IV 27.20%, IV rank 24.62%, expected move 7.80%. The long call on SBIO below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this long call structure on SBIO specifically: SBIO IV at 27.20% is on the cheap side of its 1-year range, which favors premium-buying structures like a SBIO long call, with a market-implied 1-standard-deviation move of approximately 7.80% (roughly $5.04 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated SBIO expiries trade a higher absolute premium for lower per-day decay. Position sizing on SBIO should anchor to the underlying notional of $64.69 per share and to the trader's directional view on SBIO etf.
SBIO long call setup
The SBIO long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With SBIO near $64.69, the first option leg uses a $65.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed SBIO chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 SBIO shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $65.00 | $1.60 |
SBIO long call risk and reward
- Net Premium / Debit
- -$160.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$160.00
- Breakeven(s)
- $66.60
- Risk / Reward Ratio
- Unbounded
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
SBIO long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on SBIO. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$160.00 |
| $14.31 | -77.9% | -$160.00 |
| $28.61 | -55.8% | -$160.00 |
| $42.92 | -33.7% | -$160.00 |
| $57.22 | -11.5% | -$160.00 |
| $71.52 | +10.6% | +$492.11 |
| $85.82 | +32.7% | +$1,922.33 |
| $100.13 | +54.8% | +$3,352.55 |
| $114.43 | +76.9% | +$4,782.77 |
| $128.73 | +99.0% | +$6,212.99 |
When traders use long call on SBIO
Long calls on SBIO express a bullish thesis with defined risk; traders use them ahead of SBIO catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
SBIO thesis for this long call
The market-implied 1-standard-deviation range for SBIO extends from approximately $59.65 on the downside to $69.73 on the upside. A SBIO long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current SBIO IV rank near 24.62% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on SBIO at 27.20%. As a Financial Services name, SBIO options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to SBIO-specific events.
SBIO long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. SBIO positions also carry Financial Services sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move SBIO alongside the broader basket even when SBIO-specific fundamentals are unchanged. Long-premium structures like a long call on SBIO are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current SBIO chain quotes before placing a trade.
Frequently asked questions
- What is a long call on SBIO?
- A long call on SBIO is the long call strategy applied to SBIO (etf). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With SBIO etf trading near $64.69, the strikes shown on this page are snapped to the nearest listed SBIO chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are SBIO long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the SBIO long call priced from the end-of-day chain at a 30-day expiry (ATM IV 27.20%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$160.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a SBIO long call?
- The breakeven for the SBIO long call priced on this page is roughly $66.60 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current SBIO market-implied 1-standard-deviation expected move is approximately 7.80%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on SBIO?
- Long calls on SBIO express a bullish thesis with defined risk; traders use them ahead of SBIO catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current SBIO implied volatility affect this long call?
- SBIO ATM IV is at 27.20% with IV rank near 24.62%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.